Identify a Presenting Author and up to four (4) Co-Authors. 

*The presenting author must be available to attend in person April 24 - April 26, 2026. 

**Please note that travel honoraria will not be offered.

2026 ASPO Annual Meeting

April 24 - April 26, 2026

Phoneix, AZ

In accordance with ACCME regulations, the American College of Surgeons must ensure that anyone who is in a position to control the content of the education activity has disclosed to us all relevant financial relationships with any commercial interest (see below for definitions) as it pertains to the content of the presentation. Should it be determined that a conflict of interest exists as a result of a financial relationship you may have, you will be contacted and methods to resolve the conflict will be discussed with you. In addition, all affirmative disclosures must be revealed by a slide at the beginning of the presentation. Failure or refusal to disclose or the inability to resolve the identified conflict will result in the withdrawal of the invitation to participate.

• List the names of proprietary entities producing health care goods or services, with the exemption of non-profit or government organizations and non-health care related companies with which you have, or have had, a relevant financial relationship within the past 12 months. 
• Explain what you received (i.e. salary, honorarium etc.).

What was received: Salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g. stocks, stock options, etc.), or other financial benefit.

Role: Employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, etc.

If your presentation describes the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or drug or unapproved usage, it is your responsibility to disclose this information verbally to the learner during your presentation.

Glossary of Terms

Commercial Interest

A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.  The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

Financial Relationships

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Relevant Financial Relationships 

The ACCME focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CME activity. ACCME has not set a minimal dollar amount for relationships to be significant.  Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME defines “’relevant’ financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.

Provide a brief summary of your proposed Abstract below.

• Please present in structured format (Background/ Hypothesis/ Methods/ Results/ Discussion)
• The total length of your submission should not exceed 350 words.

Please identify a Moderator and a minimum of two and a maximum of three Panelists

*The moderator and panelists must be available to attend in person April 24 - April 26, 2026. 

**Please note that travel honoraria will not be offered.

Moderator Information (Please identify one moderator):

Panelists (Please identify a minimum of two and a maximum of three panelists):

Learning Objectives:

Please list the learning objectives for the panel (what knowledge, attitudes, and skills will the audience obtain after attending your panel?).

You must provide at least 2, but no more than 5 learning objectives.